TickerFactsScreenerDevelopers

Gain Therapeutics, Inc. (GANX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$3.24M2021: -$12.37M2022: -$14.69M2023: -$18.87M2024: -$18.87M2025: -$18.47M-$18.47M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$18.47M+2.2%
2024-$18.87M-0.0%
2023-$18.87M-28.4%
2022-$14.69M-18.8%
2021-$12.37M-281.6%
2020-$3.24M—